**Core Concept**
Phenylbutyrate is a medication used in the management of urea cycle disorders, specifically to treat hyperammonemia. It belongs to the class of medications known as ammonia scavengers or detoxifiers. Phenylbutyrate works by conjugating with glutamine to form phenylacetylglutamine, which is then excreted in the urine, thereby reducing the concentration of ammonia in the blood.

**Why the Correct Answer is Right**
Phenylbutyrate is effective in urea cycle disorders because it provides an alternative route for the disposal of ammonia, which is a toxic byproduct of protein metabolism. In normal conditions, ammonia is converted to urea through the action of the urea cycle enzymes in the liver. However, in urea cycle disorders, this process is impaired, leading to elevated levels of ammonia in the blood. Phenylbutyrate helps to reduce ammonia levels by conjugating with glutamine, which is then excreted in the urine.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of phenylbutyrate in urea cycle disorders.
**Option B:** This option is incorrect because it is not a known mechanism of action of phenylbutyrate in the treatment of urea cycle disorders.
**Option C:** This option is incorrect because it is not a characteristic of phenylbutyrate in the treatment of urea cycle disorders.

**Clinical Pearl / High-Yield Fact**
It is essential to note that phenylbutyrate is not a cure for urea cycle disorders but rather a treatment to manage symptoms and prevent complications associated with hyperammonemia.

**Correct Answer:** C.